Major breakthrough in hepatitis C vaccine development
Researchers at the Burnet Institute have solved a hepatitis C vaccine mystery which, once developed could be the first ever preventative vaccine for the virus.
Currently undergoing formal preclinical studies, the vaccine is the result of breakthrough work done by Associate Professor Heidi Drummer with her team from the Institute’s Centre for Virology.
Hepatitis C affects around 200 million people around the world – a preventative vaccine has the potential to have a significant global health impact.
Associate Professor Drummer and her team have overcome a major hurdle in HCV vaccine research, developing a vaccine candidate that protects against a number of different HCV strains.
“Hepatitis C has a great ability to change its structure and evade the immune response. This makes vaccine development challenging,” Associate Professor Drummer said.
“Our vaccine is unique as it contains only the most essential, conserved parts of the major viral surface protein, eliciting antibodies that prevent both closely and distantly related hepatitis C viruses from entering cells, thereby preventing infection.”
Source: Burnet Institute
Article Date: 29/8/2012
- Drug Boosts Platelets in Hepatitis C Patients
- Coffee drinking improves hepatitis C treatment response
- Sustained virological response associated with improved survival for certain patients with chronic hepatitis C virus infection
- Monogamous heterosexuals unlikely to transmit Hepatitis C
Rate this article
List News by Medical Area
Australia’s leading source for trustworthy medical information written by health professionals.
Please be aware that we do not give advice on your individual medical condition,
Parenting information is available at Parenthub.com.au
|^ Back to Top|